A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle

BMJL Mannaerts, study gr The ganirelix dose finding, D (Diederick) de Jong, BCJM (Bart) Fauser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3023-3031
Number of pages9
JournalHuman Reproduction
Issue number11
Publication statusPublished - 1998

Research programs

  • EMC MM-01-52-07

Cite this